Ligand validation:4IIF

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4IIF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IIF_NAG_B_944	52%	43%	0.214	0.974	0.7	1.49	-	1	0	0	100%	0.9333
4IIF_NAG_A_937	43%	25%	0.236	0.962	1	2	-	6	0	0	100%	0.9333
4IIF_NAG_A_905	34%	42%	0.223	0.906	0.74	1.51	-	2	0	0	100%	0.9333
4IIF_NAG_B_943	31%	39%	0.229	0.897	0.73	1.62	-	2	0	0	100%	0.9333
4IIF_NAG_B_908	25%	34%	0.235	0.869	1.06	1.53	1	4	0	0	100%	0.9333
4IIH_NAG_B_947	73%	45%	0.133	0.959	0.86	1.24	-	-	0	0	100%	0.9333
4IIE_NAG_A_938	70%	26%	0.13	0.948	0.8	2.14	1	7	0	0	100%	0.9333
4IID_NAG_A_937	68%	39%	0.144	0.956	0.57	1.79	-	3	0	0	100%	0.9333
4IIC_NAG_A_939	67%	22%	0.146	0.955	1.07	2.12	1	8	0	0	100%	0.9333
4IIB_NAG_B_946	67%	38%	0.163	0.971	0.83	1.58	-	2	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.83	0.93	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	100%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.